OKYO Pharma Ltd

OKYO · XNAS

CIK 1849296fmd_0P4TCJPDPHG0A28MWCNG7ZX42PManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Apr 01, 2019 to Mar 31, 2026, 7 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.